共 22 个 OTC 专论产品
| 序号 | NDC编码 | 商品名 | 剂型 | 上市日期 | 专论编号 |
|---|---|---|---|---|---|
| 1 | 85384-0002-1 | Tagrit Antifungal Treament Ketoconazole 1% | CREAM | 2025-04-18 | M005 |
| 2 | 85384-0001-1 | 1% ketoconazole | SHAMPOO | 2025-03-31 | M005 |
| 3 | 85384-0003-1 | Tagrid Jock Itch Miconazole Nitrate 2% | CREAM | 2025-04-22 | M005 |
| 4 | 85384-0004-1 | Folliculitis Treatment Cream | CREAM | 2025-04-22 | M005 |
| 5 | 85384-0009-1 | Tagrid Jock Itch | SPRAY | 2025-06-04 | M005 |
| 6 | 85384-0006-1 | Tagrid Antifungal Ringworm Treatment 1% CLOTRIMAZOLE | CREAM | 2025-05-20 | M005 |
| 7 | 85384-0008-1 | Tagrid Athletes Foot Treament | CREAM | 2025-05-30 | M005 |
| 8 | 85384-0013-1 | Tagrid Antifungal | SOAP | 2025-06-09 | M005 |
| 9 | 85384-0010-1 | Tagrid Antifungal | SOAP | 2025-06-09 | M005 |
| 10 | 85384-0012-1 | Tagrid Antifungal Treament Clotrimazole 1% | CREAM | 2025-07-09 | M005 |
| 11 | 85384-0014-1 | Tagrid Antifungal Kit | KIT | 2025-06-09 | M005 |
| 12 | 85384-0018-1 | Tagrid Balanitis Relief | CREAM | 2025-11-14 | M005 |
| 13 | 85384-0019-1 | Tagrid Antifungal Clotrimazole 1% | CREAM | 2023-06-28 | M005 |
| 14 | 85384-0024-1 | Tagrid Eczema Cream Colloidal Oatmeal 1% | CREAM | 2026-05-15 | M005 |
| 15 | 85384-0021-1 | Tagrid Antifungal Jock Itch Cream Non-Steroidal Clotrimazole 1% | CREAM | 2026-03-15 | M005 |
| 16 | 85384-0022-1 | Tagrid Intertrigo Cream For Skin Fold Rash Clotrimazole 1% | CREAM | 2026-05-15 | M005 |
| 17 | 85384-0023-1 | Tagrid Feminine Itch Relief Cream Antifungal Formula Clotrimazole 1% | CREAM | 2026-05-15 | M005 |
| 18 | 85384-0007-1 | Tagrid Skin Repair Cream | CREAM | 2025-05-23 | M016 |
| 19 | 85384-0011-1 | Bed Sore and Wound Healing Cream | CREAM | 2025-06-02 | M016 |
| 20 | 85384-0016-1 | TAGRID TINEA VERSICOLOR | CREAM | 2025-07-19 | M016 |
| 21 | 85384-0017-1 | Tagrid Athlete Foot Antifungal with Tolnaftate | SPRAY | 2025-08-10 | M016 |
| 22 | 85384-0005-1 | Tagrid ANTI FUNGAL | SHAMPOO | 2025-05-22 | M032 |
标准化流程确保专论判定准确、文件齐备、标签合规,缩短整体办理周期。
提交配方表、活性成分、宣称用途及现有检测报告,进行初步合规评估。
比对21 CFR对应专论条款,确认产品归属类别及GRASE活性成分浓度范围。
指定美国代理人,完成FDA药品生产设施注册与产品列名申请。
按21 CFR 201.66制作Drug Facts标签,核对警示语、适应症与使用方法。
提供完整合规文件包,协助清关申报与上市后持续合规维护。
关于 OTC 化妆品出口美国合规的常见疑问解答。
微信号:KOL123567
添加时请备注「公司-职务-姓名」
优先安排资深法规专家 1 对 1 对接
我们已收到您的合规咨询需求
资深 FDA 法规顾问将在 1 个工作日内与您联系